ebv1

Treatment resistance in diffuse large

Therapy resistance in diffuse massive B-cell lymphoma

Diffuse massive B-cell lymphoma (DLBCL) is a extremely heterogeneous illness and represents the most typical subtype of lymphoma. Though 60-70% of all sufferers will be cured by the present normal of care within the frontline setting, nearly all of the remaining sufferers will expertise remedy resistance and have a poor medical consequence. Quite a few efforts have been made to enhance the efficacy of the usual routine by, for instance, dose intensification or including novel brokers. Nevertheless, these outcomes typically did not exhibit important medical advantages.

Therefore, understanding remedy resistance is a urgent have to optimize the end result of these sufferers. On this Evaluate, we first describe the conceptual sources of remedy resistance in DLBCL after which present detailed and up-to-date molecular perception into the mechanisms of resistance to the present remedy choices in DLBCL. We lastly spotlight the potential methods for rationally managing remedy resistance from each the preventive and interventional views.

ebv1
ebv1

CMV Control lentiviral particles (Neo) in PBS

CMV-Null-Neo-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (Puro) in PBS

CMV-Null-Puro-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (GFP-Bsd) in PBS

CMV-Null-GB-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (GFP-Puro) in PBS

CMV-Null-GP-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (RFP-Bsd) in PBS

CMV-Null-RB-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (RFP-Puro) in PBS

CMV-Null-RP-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.

MT1P3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701007 1.0 ug DNA
EUR 450

LOC284297 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701013 1.0 ug DNA
EUR 450

LOC149837 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701019 1.0 ug DNA
EUR 450

GHRLOS2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701025 1.0 ug DNA
EUR 450

LINC00469 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701031 1.0 ug DNA
EUR 450

INGX Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701037 1.0 ug DNA
EUR 450

ABCA11P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701049 1.0 ug DNA
EUR 450

NCOR1P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701061 1.0 ug DNA
EUR 450

ZDHHC8P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701067 1.0 ug DNA
EUR 450

FLJ26850 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701073 1.0 ug DNA
EUR 450

OCLM Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701079 1.0 ug DNA
EUR 450

LINC00314 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701085 1.0 ug DNA
EUR 450

GSTTP1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701091 1.0 ug DNA
EUR 450

LOC285679 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701097 1.0 ug DNA
EUR 450

VN1R3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701103 1.0 ug DNA
EUR 450

MT1DP Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701115 1.0 ug DNA
EUR 450

LINC00313 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701127 1.0 ug DNA
EUR 450

LOC222699 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701139 1.0 ug DNA
EUR 450

LINC00161 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701145 1.0 ug DNA
EUR 450

LOC440419 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701151 1.0 ug DNA
EUR 450

KCNQ1DN Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701157 1.0 ug DNA
EUR 450

RBMS1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701175 1.0 ug DNA
EUR 450

MIR22HG Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701181 1.0 ug DNA Ask for price

C22orf34 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701187 1.0 ug DNA
EUR 450

ZNF663 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701193 1.0 ug DNA
EUR 450

AKR1CL1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701199 1.0 ug DNA
EUR 450

HMGB3P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701205 1.0 ug DNA
EUR 450

ASIP Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701211 1.0 ug DNA
EUR 450

LOC149950 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701217 1.0 ug DNA
EUR 450

BOLA2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701223 1.0 ug DNA
EUR 450

LOC441108 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701229 1.0 ug DNA
EUR 450

FLJ16126 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701235 1.0 ug DNA
EUR 450

LOC728032 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701241 1.0 ug DNA
EUR 450

C21orf67 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701253 1.0 ug DNA
EUR 450

TP53TG3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701259 1.0 ug DNA
EUR 450

OSTBETA Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701265 1.0 ug DNA
EUR 450

FLJ33360 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701271 1.0 ug DNA
EUR 450

LOC441208 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701277 1.0 ug DNA
EUR 450

C12orf36 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701283 1.0 ug DNA
EUR 450

LOC153684 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701289 1.0 ug DNA
EUR 450

LOC399900 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701295 1.0 ug DNA
EUR 450

LOC149134 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701301 1.0 ug DNA
EUR 450

LINC00173 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701313 1.0 ug DNA
EUR 450

LITAF Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701319 1.0 ug DNA
EUR 450

HIST1H2AI Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701325 1.0 ug DNA
EUR 450

LOC440905 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701331 1.0 ug DNA
EUR 450

LOC339535 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701337 1.0 ug DNA
EUR 450

LOC643210 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701343 1.0 ug DNA
EUR 450

LOC440337 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701349 1.0 ug DNA
EUR 450

BEX1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701355 1.0 ug DNA
EUR 450

HIST2H2AA4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701361 1.0 ug DNA
EUR 450

LPAL2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701367 1.0 ug DNA
EUR 450

LOC340094 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701373 1.0 ug DNA
EUR 450

LINC00574 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701379 1.0 ug DNA
EUR 450

CIB2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701385 1.0 ug DNA
EUR 450

SNX12 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701397 1.0 ug DNA
EUR 450

FLJ44006 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701403 1.0 ug DNA
EUR 450

C15orf37 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701409 1.0 ug DNA
EUR 450

PLAC2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701415 1.0 ug DNA
EUR 450

BTG2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701421 1.0 ug DNA
EUR 450

FLJ40448 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701445 1.0 ug DNA
EUR 450

CIB3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701451 1.0 ug DNA
EUR 450

PRDX5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701457 1.0 ug DNA
EUR 450

FLJ45256 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701463 1.0 ug DNA
EUR 450

C21orf67 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701469 1.0 ug DNA
EUR 450

LINC00477 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701475 1.0 ug DNA
EUR 450

LOC348262 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701487 1.0 ug DNA
EUR 450

SHISA4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701493 1.0 ug DNA
EUR 450

LOC400707 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701499 1.0 ug DNA
EUR 450

FLJ41423 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701505 1.0 ug DNA
EUR 450

FLJ46257 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701511 1.0 ug DNA
EUR 450

FKSG83 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701517 1.0 ug DNA
EUR 450

FLJ25328 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701523 1.0 ug DNA
EUR 450

LOC84931 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701529 1.0 ug DNA
EUR 450

LOC389791 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701535 1.0 ug DNA
EUR 450

LOC338809 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701541 1.0 ug DNA
EUR 450

LOC441251 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701553 1.0 ug DNA
EUR 450

INSL6 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701559 1.0 ug DNA
EUR 450

C1orf222 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701565 1.0 ug DNA
EUR 450

SFTPA2B Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701571 1.0 ug DNA
EUR 450

CCDC102B Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701595 1.0 ug DNA
EUR 450

C1QTNF3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701601 1.0 ug DNA
EUR 450

OTOGL Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701607 1.0 ug DNA
EUR 450

LHPP Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701613 1.0 ug DNA
EUR 450

Resistant hyponatraemia in a affected person with follicular lymphoma and coronary heart failure with decreased ejection fraction: a case report

Background: Hyponatraemia is a frequent drawback in sufferers with coronary heart failure. It may be tough to deal with, particularly within the presence of the affected person’s wants for diuresis and manipulation of the renin-angiotensin-aldosterone system (RAAS).

Case abstract: This issues a 74-year-old lady with follicular lymphoma and extreme world left ventricular systolic dysfunction secondary to remedy with R-CHOP chemotherapy. She offered a tough problem within the administration of her decompensated coronary heart failure alongside hyponatraemia as little as 113 mmol/L. This was resistant to plain remedy. The resistance to typical measures necessitated remedy with Tolvaptan, a selective arginine vasopressin V2 inhibitor used to deal with hyponatraemia in syndrome of inappropriate anti-diuretic hormone. This, together with a strict fluid restriction of 500 mL/day, resolved the affected person’s hyponatraemia and enabled her discharge house on tolerated coronary heart failure remedy. She has now remained steady for nearly 12 months.

Dialogue: The potential causes of hyponatraemia are mentioned together with the function of Tolvaptan in its administration.

Regional Mind Glucose Metabolism and Its Prognostic Worth in Pretreatment Extranodal Pure Killer/T-Cell Lymphoma Sufferers

Goal: To discover regional mind glucose metabolic abnormalities of pretreatment stage I/II extranodal pure killer/T-cell lymphoma (ENKTL) sufferers utilizing positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro-D-glucose built-in with computed tomography (18F-FDG PET/CT) and assess its prognostic worth.

Strategies: Sixty pretreatment stage I/II ENKTL sufferers have been enrolled on this retrospective examine and divided into survival (n = 45) and loss of life (n = 15) teams in response to their standing on the finish of follow-up. A management group consisted of 60 wholesome topics. Regional cerebral glucose metabolism was evaluated on a voxel-by-voxel foundation utilizing statistical parametric mapping (SPM8) underneath a sure significance stage (P < 0. 001) and voxel threshold (Ok = 100 voxels).

Outcomes: Decreased metabolism was famous in sufferers, involving the bilateral prefrontal and orbitofrontal cortex, partial parietal and occipital cortex, cingulate gyrus and cerebellum; the sensorimotor cortex was largely spared. Elevated metabolism was noticed within the bilateral putamen, amygdala, and parahippocampal gyrus. In contrast with the survival group, the loss of life group had greater metabolism within the bilateral amygdala, putamen, left thalamus, uncus, and parahippocampal gyrus. Solely B signs have been related to the elevated metabolism of basal ganglia and thalamus (BGT). Sufferers with excessive metabolic tumor quantity, complete lesion glycolysis (TLG) and BGT metabolism had a poor prognosis. TLG and most standardized uptake worth (SUVmax) LBGT/SUVmaxRight cerebellum have been related to Jap Cooperative Oncology Group (ECOG) and prognostic index of pure killer lymphoma and Epstein-Barr virus-DNA (PINKE) scores. In multivariate evaluation, solely ECOG was an unbiased prognostic issue of each progression-free survival (PFS) and total survival (OS). PINKE was an unbiased prognostic issue of OS.

Conclusion: Pretreatment stage I/II ENKTL sufferers exhibited irregular regional cerebral glucose metabolism. Greater pretreatment glucose metabolism in BGT might predict a comparatively poor prognosis however didn’t surpass the predictive values of ECOG and PINKE in stage I/II ENKTL sufferers.

Prognosis and Individualized Therapy of Secondary Central Nervous System Lymphoma: A Case Report

Non-Hodgkin lymphoma can disseminate to the central nervous system at initiation of remedy for systemic lymphoma or unfold in the course of the relapse of systematic lymphoma with CNS involvement, which is outlined as secondary central nervous system lymphoma (SCNSL). The incidence of SCNSL relies on the pathological sort of lymphoma and is very excessive in aggressive lymphoma. SCNSL has a poor prognosis due to the shortage of efficient remedy regimens.

This text presents a uncommon case of SCNSL; an individualized remedy routine was designed in response to the genetic analyses of the affected person tumor and included a Bruton’s tyrosine kinase (BTK) inhibitor. After six cycles of remedy and one other two cycles of rituximab, most lesions misplaced their metabolic exercise. Nevertheless, within the last stage of remedy, our affected person sadly suffered from respiratory failure, which revealed that we must always pay consideration to Pneumocystis jirovecii pneumonia throughout ibrutinib remedy.

The medical potential of circulating immune cell counts in major gastric lymphoma

Background: Excessive neutrophil-lymphocyte ratio (NLR) is linked to poor total survival (OS) in gastrointestinal tract cancers. This examine explores the medical worth of NLR, along with absolute lymphocyte rely (ALC) and different hematologic parameters in affiliation with distant metastases and OS in major gastric lymphoma (PGL) sufferers.

Strategies: Scientific information of 139 PGL sufferers who acquired remedy at King Hussein Most cancers Middle (KHCC), Amman-Jordan have been retrospectively evaluated. Utilizing information from full blood rely (CBC) exams, the next hematologic parameters: absolute neutrophil rely (ANC), ALC, absolute eosinophil rely (AEC), absolute monocyte rely (AMC), NLR, platelet-lymphocyte ratio (PLR), and monocyte-lymphocyte ratio (MLR) have been assessed in affiliation with the next medical outcomes: presence or absence of baseline distant metastases and OS. We carried out univariate and multivariate analyses assessing the varied hematologic parameters in affiliation with distant metastases.

Outcomes: Univariate and multivariate analyses indicated that sufferers with an elevated NLR (>3.14) displayed extra baseline distant metastases in comparison with sufferers with a low NLR (≤3.14), (P worth: 0.02 and 0.018, respectively). Excessive baseline ALC (>1,819/µL) was related to decrease baseline distant metastases (P worth: 0.04). Within the OS evaluation, excessive baseline ANC (>5,100/µL), NLR (>2.75), and PLR (>0.16) have been related to poor OS, (P worth: 0.027, 0.016, and 0.011 respectively).

Conclusions: Excessive NLR and ALC have been related to baseline distant metastases. Excessive baseline ANC, NLR, and PLR have been related to poor OS. Hematologic parameters could be probably useful in assessing and correlating NLR with the response success to remedy in PGL.

EF1a Control lentiviral particles (Neo) in PBS

EF1a-Null-Neo-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter. The virus was concentrated and provided in PBS solution.

EF1a Control lentiviral particles (Puro) in PBS

EF1a-Null-Puro-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. The virus was concentrated and provided in PBS solution.

EF1a Control lentiviral particles (GFP-Bsd) in PBS

EF1a-Null-GB-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.

EF1a Control lentiviral particles (GFP-Puro) in PBS

EF1a-Null-GP-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.

EF1a Control lentiviral particles (RFP-Bsd) in PBS

EF1a-Null-RB-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.

EF1a Control lentiviral particles (RFP-Puro) in PBS

EF1a-Null-RP-PBS 1 x108 IFU/ml x 200ul
EUR 710
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.

HPC1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728674 1.0 ug DNA Ask for price

HPCX Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728680 1.0 ug DNA Ask for price

HPE1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728686 1.0 ug DNA Ask for price

HPFH2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728692 1.0 ug DNA Ask for price

HPLH1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728698 1.0 ug DNA Ask for price

HPP1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728704 1.0 ug DNA Ask for price

HPRTP2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728710 1.0 ug DNA Ask for price

HPRTP3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728716 1.0 ug DNA Ask for price

HPRTP4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728722 1.0 ug DNA Ask for price

HPT Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728728 1.0 ug DNA Ask for price

HPV6AI1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728734 1.0 ug DNA Ask for price

HPV18I1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728740 1.0 ug DNA Ask for price

HPV18I2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728746 1.0 ug DNA Ask for price

HRES1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728752 1.0 ug DNA Ask for price

HRPT1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728758 1.0 ug DNA Ask for price

HSBP1P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728776 1.0 ug DNA Ask for price

HSD3BP1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728782 1.0 ug DNA Ask for price

HSD3BP2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728788 1.0 ug DNA Ask for price

HSD3BP3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728794 1.0 ug DNA Ask for price

HSD3BP4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728800 1.0 ug DNA Ask for price

HSD3BP5 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728806 1.0 ug DNA Ask for price

HSFX2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728812 1.0 ug DNA Ask for price

HSFY4P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728818 1.0 ug DNA Ask for price

HSFY5P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728824 1.0 ug DNA Ask for price

HSFY6P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728830 1.0 ug DNA Ask for price

HSFY7P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728836 1.0 ug DNA Ask for price

HSFY8P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728842 1.0 ug DNA Ask for price

HSP90AA5P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728848 1.0 ug DNA Ask for price

HSP90AA6P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728854 1.0 ug DNA Ask for price

HSP90AB5P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728860 1.0 ug DNA Ask for price

HSP90AB6P Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728866 1.0 ug DNA Ask for price

HSPA8P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728872 1.0 ug DNA Ask for price

HSPA9P2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728878 1.0 ug DNA Ask for price

HSPD1P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728884 1.0 ug DNA Ask for price

HSPD1P2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728890 1.0 ug DNA Ask for price

HSPD1P3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728896 1.0 ug DNA Ask for price

HSPD1P4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728902 1.0 ug DNA Ask for price

HSPD1P7 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728908 1.0 ug DNA Ask for price

HSPD1P8 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728914 1.0 ug DNA Ask for price

HSPD1P9 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728920 1.0 ug DNA Ask for price

HSPD1P10 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728926 1.0 ug DNA Ask for price

HSPD1P12 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728932 1.0 ug DNA Ask for price

HSPD1P15 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728938 1.0 ug DNA Ask for price

HSPE1P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728944 1.0 ug DNA Ask for price

HSPE1P2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728950 1.0 ug DNA Ask for price

HTATSF1P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728956 1.0 ug DNA Ask for price

HTC1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728962 1.0 ug DNA Ask for price

HTC2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728968 1.0 ug DNA Ask for price

HTL Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728974 1.0 ug DNA Ask for price

HTLVR Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728980 1.0 ug DNA Ask for price

HTOR Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV728986 1.0 ug DNA Ask for price

HTX2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729022 1.0 ug DNA Ask for price

HV1S Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729028 1.0 ug DNA Ask for price

HVBS7 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729034 1.0 ug DNA Ask for price

HVBS8 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729040 1.0 ug DNA Ask for price

HYD2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729046 1.0 ug DNA Ask for price

IBD2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729058 1.0 ug DNA Ask for price

IBD3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729064 1.0 ug DNA Ask for price

IBD4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729070 1.0 ug DNA Ask for price

IBD5 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729076 1.0 ug DNA Ask for price

IBD6 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729082 1.0 ug DNA Ask for price

IBD7 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729088 1.0 ug DNA Ask for price

IBD8 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729094 1.0 ug DNA Ask for price

IBD9 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729100 1.0 ug DNA Ask for price

IBGC1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729106 1.0 ug DNA Ask for price

IBM3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729112 1.0 ug DNA Ask for price

IBTKP1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729118 1.0 ug DNA Ask for price

ICCA Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729124 1.0 ug DNA Ask for price

ICR1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729130 1.0 ug DNA Ask for price

ICR3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729136 1.0 ug DNA Ask for price

ICR4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729142 1.0 ug DNA Ask for price

ICR5 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729148 1.0 ug DNA Ask for price

ICS1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729154 1.0 ug DNA Ask for price

IDDM2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729160 1.0 ug DNA Ask for price

IDDM3 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729166 1.0 ug DNA Ask for price

IDDM4 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729172 1.0 ug DNA Ask for price

IDDM5 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729178 1.0 ug DNA Ask for price

IDDM6 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729184 1.0 ug DNA Ask for price

IDDM7 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729190 1.0 ug DNA Ask for price

IDDM8 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729196 1.0 ug DNA Ask for price

IDDM9 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729202 1.0 ug DNA Ask for price

IDDM10 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729208 1.0 ug DNA Ask for price

IDDM11 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729214 1.0 ug DNA Ask for price

IDDM12 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV729220 1.0 ug DNA Ask for price

Leave a Reply

Your email address will not be published.